User profiles for Duygu Has Simsek
duygu has simsekIstanbul University Verified email at istanbul.edu.tr Cited by 610 |
Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic …
Gastroenteropancreatic neuroendocrine tumors (GEPNETs) are indolent neoplasms
presenting unpredictable and unusual biologic behavior that causes many clinical challenges. …
presenting unpredictable and unusual biologic behavior that causes many clinical challenges. …
[HTML][HTML] 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
The aim of this narrative review is to evaluate the current status of 177 Lu-PSMA (prostate
specific membrane antigen) therapy for metastatic castration-resistant prostate cancer (…
specific membrane antigen) therapy for metastatic castration-resistant prostate cancer (…
Evidence of prostate-specific membrane antigen expression in hepatocellular carcinoma using 68Ga-PSMA PET/CT
S Kuyumcu, D Has-Simsek, R Iliaz, Y Sanli… - Clinical nuclear …, 2019 - journals.lww.com
Materials and Methods Nineteen HCC patients who underwent 18 F-fluorodeoxyglucose (18
F-FDG) positron emission tomography (PET) as part of restaging procedure also underwent …
F-FDG) positron emission tomography (PET) as part of restaging procedure also underwent …
Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?
Purpose We investigated the role of PSMA-derived tumor burden in predicting docetaxel (DTX)
therapy response in metastatic castration-resistant prostate cancer (mCRPC). Methods …
therapy response in metastatic castration-resistant prostate cancer (mCRPC). Methods …
Detection of metastases in newly diagnosed prostate cancer by using 68Ga-PSMA PET/CT and its relationship with modified D'Amico risk classification
Purpose We aimed to investigate the diagnostic power of 68Ga-PSMA PET/CT in the detection
of metastatic spread of newly diagnosed PCa, and evaluate the relationship with modified …
of metastatic spread of newly diagnosed PCa, and evaluate the relationship with modified …
Safety of fibroblast activation protein–targeted radionuclide therapy by a low-dose dosimetric approach using 177Lu-FAPI04
…, Y Sanli, F Buyukkaya, DH Simsek… - Clinical nuclear …, 2021 - journals.lww.com
… The role of nonneoplastic cells within the tumor microenvironment (TME) has
increasingly been a focus of interest due to their role in tumor progression and therapeutic …
increasingly been a focus of interest due to their role in tumor progression and therapeutic …
Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?
Objection We aimed to evaluate the role of bone scintigraphy (BS) which has long been the
imaging modality of choice in prostate cancer (PCa) and performed a head-to-head …
imaging modality of choice in prostate cancer (PCa) and performed a head-to-head …
Prognostic significance of 68Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to 18F-FDG PET/CT and laboratory results
Purpose This study investigates the prognostic value of 68 Ga-Pentixafor PET/CT using PET-derived
quantitative in multiple myeloma (MM) patients with suspected recurrence in …
quantitative in multiple myeloma (MM) patients with suspected recurrence in …
Fibroblast activation protein–targeted PET imaging of metastatic castration-resistant prostate cancer compared with 68Ga-PSMA and 18F-FDG PET/CT
Herein we present 2 mCRPC (metastatic castration-resistant prostate cancer) patients who
underwent 68 Ga-PSMA PET/CT for PSMA-targeted radioligand therapy eligibility. Prior …
underwent 68 Ga-PSMA PET/CT for PSMA-targeted radioligand therapy eligibility. Prior …
The role of [68 Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study
Purpose We aimed to investigate the role of [ 68 Ga]Ga-FAPI-04 PET/CT and uptake patterns
of primary and metastatic lesions in patients with renal cell carcinoma (RCC). Methods …
of primary and metastatic lesions in patients with renal cell carcinoma (RCC). Methods …